Palliative therapy of non-resectable cholangiocarcinoma;Palliative therapie des inoperablen gallengangskarzinoms

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 36, 2002, Pages 1835-1839

  Gerhardt, T ^a   Mey, U ^a   Sauerbruch, T ^a   Dumoulin, F L ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRIDIUM 192; IRINOTECAN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PHOTOSENSITIZING AGENT; RECOMBINANT ALPHA2B INTERFERON; SEMUSTINE; STREPTOZOCIN;

BEAM THERAPY; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON RADIATION; ENDOSCOPIC BIOPSY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL SYMPTOM; HEMIHEPATECTOMY; HUMAN; INCIDENCE; INOPERABLE CANCER; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NEUTROPENIA; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; REVIEW; SKIN TOXICITY; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; DRAINAGE; HUMANS; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; RADIOTHERAPY, ADJUVANT;

EID: 0037031983     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-33880     Document Type: Review

References (67)

1. Adamek HE, Albert J, Weitz M, Breer H, Schilling D, Riemann JF. A prospective evaluation of magnetic resonance cholangiopancreatography in patients with suspected bile duct obstruction. Gut 1998; 43: 680-683
2. Alden ME, Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994; 28: 945-951
3. Arroyo G, Gallardo J, Rubio B et al. Gemcitabine in advanced biliary tract cancer, Experience from Chile and Argentina in phase II trials. Proc Am Soc Clin Oncol 2001; 20: 626a
4. Arslan A, Geitung JT, Viktil E, Abdelnoor M, Osnes M. Pancreaticobiliary diseases. Comparison of 2D single-shot turbo spin-echo MR cholangiopancreatography with endoscopic retrograde cholangiopancreatography. Acta Radiol 2000; 41: 621-626
5. Berr F, Liebetruth J, Caca K et al. Photodynamic therapy of non-resectable cholangiocarcinoma - first results of a randomized study. Journal of Hepatology 2001; 34: 107; 1540a
6. Berr F, Wiedmann M, Tannapfel A et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000; 31: 291-298
7. Bismuth H. Revisiting liver transplantation for patients with hilar cholangiocarcinoma: the Mayo Clinic proposal. Liver Transpl 2000; 6: 317-319
8. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38
9. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996; 39: 852-855
10. Bruha R, Petrtyl J, Kubecova M et al. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies - the question of long-term palliation. Hepatogastroenterology 2001; 48: 631-637
11. Chen JS, Jan YY, Lin YC, Wang HM, Chang WC, Liau CT. Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas. Anticancer Drugs 1998; 9: 393-397
12. Chen JS, Lin YC, Jan YY, Liau CT. Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. Anticancer Drugs 2001; 12: 339-343
13. Choi CW, Choi IK, Seo JH et al. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. Am J Clin Oncol 2000; 23: 425-428
14. Davids PH, Groen AK, Rauws EA, Tytgat GN. Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340: 1488-1492
15. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378
16. De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001; 53: 547-553
17. De Vreede I, Steers JL, Burch PA et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6: 309-316
18. Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988; 34: 95-101
19. Ducreux M, Rougier P, Fandi A et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 1998; 9: 653-656
20. Dumoulin F-L, Gerhardt T, Scheurlen C, Neubrand M, Layer G, Sauerbruch T. Palliative photodynamische Therapie des inoperablen Gallengangskarzinoms: Interimsanalyse einer prospektiven Studie. Zeitschrift für Gastroenterologie (German Journal of Gastroenterology) 2001; 39: 668a
21. Ellis PA, Norman A, Hill A et al. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer 1995; 31A: 1594-1598
22. Eschelman DJ, Shapiro MJ, Bonn J et al. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology 1996; 200: 717-724
23. Falkson G, MacIntyre JM, Moertel CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984; 54: 965-969
24. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997; 39: 929-935
25. Gonzalez Gonzalez D, Gouma DJ, Rauws EA et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 1999; 10: 215-220
26. Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg 1991; 161: 454-458
27. Harvey JH, Smith FP, Schein PS. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. J Clin Oncol 1984; 2: 1245-1248
28. Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998; 34: 977-986
29. Hintze RE, Abou-Rebyeh H, Adler A et al. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001; 53: 40-46
30. Iwatsuki S, Todo S, Marsh JW et al.: Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187: 358-364
31. Jailwala J, Fogel EL, Sherman S et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000; 51: 383-390
32. Jones DV Jr, Lozano R, Hoque A, Markowitz A, Patt YZ. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol 1996; 14: 2306-2310
33. Kajanti M, Pyrhonen S. Epirubicin-sequential methotrexate-5-fluorouracilleucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study. Am J Clin Oncol 1994; 17: 223-226
34. Klempnauer J, Ridder GJ, Werner M et al. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79: 26-34
35. Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993; 25: 207-212
36. Kuhn R, Ridwelski K, Eichelmann K et al. Outpatient combination chemotherapy with gemcitabine and docetaxel in patients with cancer of the biliary system. Proc Am Soc Clin Oncol 2001; 20: 2272a
37. Kuvshinoff BW, Armstrong JG, Fong Y et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995; 82: 1522-1525
38. Launois B, Reding R, Lebeau G, Buard JL. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000; 7: 128-134
39. Lee BH, Choe DH, Lee JH, Kim KH, Chin SY. Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol 1997; 168: 741-745
40. Lee CK, Barrios BR, Bjarnason H. Biliary tree malignancies: the University of Minnesota experience. J Surg Oncol 1997; 65: 298-305
41. Lossef SV, Druy E, Jelinger E, Fleischer D, Barth KH. Use of hot-tip laser probes to recanalize occluded expandable metallic biliary endoprostheses. AJR Am J Roentgenol 1992; 158: 199-201
42. Mezger J, Sauerbruch T, Ko Y, Wolter H, Funk C, Glasmacher A. Phase II study with Gemcitabine in Gallbladder and Biliary Tract Carcinomas. Onkologie 1998; 21: 232-234
43. Nomura M, Yamakado K, Nomoto Y et al. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer. Int J Oncol 2002; 20: 325-331
44. Ogura Y, Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 1998; 85: 20-24
45. Okada S, Ishii H, Nose H et al. A phase II study of cisplatin in patients with biliary tract carcinoma. Oncology 1994; 51: 515-517
46. Ortner MA, Liebetruth J, Schreiber S et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536-542
47. Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998; 47: 58-62
48. Papakostas P, Kouroussis C, Androulakis N et al. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 2001; 37: 1833-1838
49. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 199 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-207
50. Patt YZ, Hassan MM, Lozano RD et al. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res 2001; 7: 3375-3380
51. Pazdur R, Royce ME, Rodriguez Gl et al. Phase II trial of docetaxel for cholangiocarcinoma. Am J Clin Oncol 1999; 22: 78-81
52. Penz M, Kornek GV, Raderer M et al. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001; 12: 183-186
53. Polydorou AA, Cairns SR, Dowsett JF et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991; 32: 685-689
54. Polydorou AA, Chisholm EM, Romanos AA et al. A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction. Endoscopy 1989; 21: 266-271
55. Prat F, Chapat O, Ducot B et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998; 47: 1-7
56. Raderer M, Hejna MH, Valencak JB et al. Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 1999; 56: 177-180
57. Sanz-Altamira PM, Ferrante K, Jenkins RL, Lewis WD, Huberman MS, Stuart KE. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998; 82: 2321-2325
58. Sanz-Altamira PM, O'Reilly E, Stuart KE et al. A phase II trial of innotecan (CPT-11) for unresectable biliary tree carcinoma. Ann Oncol 2001; 12: 501-504
59. Schmoll H-J, Höffgen K, Possinger K. Kompendium Internistische Onkologie. Berlin Heidelberg New York: Springer-Verlag. 1999; 3. Auflage: 1096
60. Shim CS, Lee YH, Cho YD et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 1998; 30: 345-350
61. Shinchi H, Takao S, Nishida H, Aikou T. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 2000; 75: 89-94
62. Speer AG, Cotton PB, Russell RC et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; 2: 57-62
63. Taal BG, Audisio RA, Bleiberg H et al. Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Ann Oncol 1993; 4: 607-609
64. Tham TC, Carr-Locke DL, Vandervoort J et al. Management of occluded biliary Wallstents. Gut 1998; 42: 703-707
65. Todoroki T. Radiotherapy as a component of multidisciplinary treatment of bile duct cancer: a surgeon's perspective. J Hepatobiliary Pancreat Surg 2001; 8: 130-136
66. Urego M, Flickinger JC, Carr BI. Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1999; 44: 121-126
67. Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy 1993; 25: 213-218